Baylor Frantz

Title: Innovator Spotlight: Baylor Frantz and His Contribution to Hyaluronidase Enzyme Formulations

Introduction: Baylor Frantz is a notable inventor based in San Diego, California, who has made significant contributions to the field of biochemistry. His innovative work focuses on hyaluronidase enzyme formulations that enhance drug delivery systems, thereby advancing therapeutic applications.

Latest Patents: Frantz holds a patent for "Hyaluronidase enzyme formulations for high volume administration." This patent presents a formulation that includes a hyaluronidase enzyme combined with a therapeutically effective amount of an active ingredient. It also details a method for administering this formulation in a single, high-volume dosage to treat various diseases and disorders effectively.

Career Highlights: Frantz's career is marked by his collaboration with Halozyme, Inc., a company renowned for its innovative approaches in biologics and drug delivery systems. His work significantly enhances the capabilities of treatments that require high-volume delivery, positioning him as a valuable contributor in the research and development sector.

Collaborations: Throughout his career, Frantz has collaborated with esteemed professionals, including David W. Kang and Robert James Connor. These partnerships reflect a collective effort to advance medical science and create impactful solutions for healthcare challenges.

Conclusion: Baylor Frantz's contributions to the field of enzyme formulations underscore the importance of innovation in healthcare. His patent not only advances therapeutic methodologies but also exemplifies the collaborative spirit inherent in scientific research. Frantz's work at Halozyme, Inc. continues to pave the way for future developments in high-volume drug administration, which can lead to improved patient outcomes.